Bioalpha Holdings Berhad (KLSE:BIOHLDG)

Bioalpha Holdings Berhad Statistics

Total Valuation

KLSE:BIOHLDG has a market cap or net worth of MYR 21.10 million. The enterprise value is -788,586.

Market Cap	21.10M
Enterprise Value	-788,586

Important Dates

The next estimated earnings date is Wednesday, August 27, 2025.

Earnings Date	Aug 27, 2025
Ex-Dividend Date	n/a

Share Statistics

KLSE:BIOHLDG has 1.41 billion shares outstanding. The number of shares has decreased by -2.80% in one year.

Current Share Class	1.41B
Shares Outstanding	1.41B
Shares Change (YoY)	-2.80%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	16.13%
Owned by Institutions (%)	15.52%
Float	751.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.37
PB Ratio	0.23
P/TBV Ratio	0.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.02
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.30

Financial Position

The company has a current ratio of 4.52, with a Debt / Equity ratio of 0.06.

Current Ratio	4.52
Quick Ratio	3.89
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-2.08
Interest Coverage	-160.56

Financial Efficiency

Return on equity (ROE) is -47.14% and return on invested capital (ROIC) is -28.33%.

Return on Equity (ROE)	-47.14%
Return on Assets (ROA)	-24.19%
Return on Invested Capital (ROIC)	-28.33%
Return on Capital Employed (ROCE)	-56.58%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.40
Inventory Turnover	10.74

Taxes

Income Tax	-1.75M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.00% in the last 52 weeks. The beta is 2.11, so KLSE:BIOHLDG's price volatility has been higher than the market average.

Beta (5Y)	2.11
52-Week Price Change	-85.00%
50-Day Moving Average	0.02
200-Day Moving Average	0.05
Relative Strength Index (RSI)	43.78
Average Volume (20 Days)	650,095

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KLSE:BIOHLDG had revenue of MYR 57.26 million and -47.11 million in losses. Loss per share was -0.04.

Revenue	57.26M
Gross Profit	-4.85M
Operating Income	-56.03M
Pretax Income	-56.41M
Net Income	-47.11M
EBITDA	-49.39M
EBIT	-56.03M
Loss Per Share	-0.04

Balance Sheet

The company has 29.64 million in cash and 5.52 million in debt, giving a net cash position of 24.12 million or 0.02 per share.

Cash & Cash Equivalents	29.64M
Total Debt	5.52M
Net Cash	24.12M
Net Cash Per Share	0.02
Equity (Book Value)	90.88M
Book Value Per Share	0.06
Working Capital	30.33M

Cash Flow

In the last 12 months, operating cash flow was -2.69 million and capital expenditures 29,803, giving a free cash flow of -2.66 million.

Operating Cash Flow	-2.69M
Capital Expenditures	29,803
Free Cash Flow	-2.66M
FCF Per Share	-0.00

Margins

Gross margin is -8.46%, with operating and profit margins of -97.84% and -82.27%.

Gross Margin	-8.46%
Operating Margin	-97.84%
Pretax Margin	-98.51%
Profit Margin	-82.27%
EBITDA Margin	-86.25%
EBIT Margin	-97.84%
FCF Margin	n/a

Dividends & Yields

KLSE:BIOHLDG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.80%
Shareholder Yield	n/a
Earnings Yield	-223.31%
FCF Yield	-12.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 6, 2016. It was a forward split with a ratio of 1.0117668484.

Last Split Date	Dec 6, 2016
Split Type	Forward
Split Ratio	1.0117668484

Scores

KLSE:BIOHLDG has an Altman Z-Score of 1.44 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.44
Piotroski F-Score	4